Priveterra Acquisition Corp. (NASDAQ:PMGM) announced this afternoon that its special meeting, intended to approve its combination with AEON Biopharma, has been adjourned for the seventh consecutive time.
Given the SPAC’s completion deadline of August 11, it is unlikely that this will be the last adjournment we will see for this completion vote.
Initially scheduled for noon today, the meeting has now been pushed back until June 30 at 4:00 p.m. Priveterra continues to reiterate its commitment to utilizing the extended time during the postponement to further engage with its shareholders.
The deal with AEON Biopharma includes a $40 million minimum cash condition, half of which has already been secured through a $20 million commitment from existing AEON investors at $7 per share. But, Priveterra’s trust, originally totaling $276 million, has been reduced to about $20.3 million after seeing 92.7% of shares redeemed in earlier votes.
Priveterra inked its $201.8 million business combination with drug developer AEON on December 13. Irvine, California-based AEON is working on an injection-based migraine treatment to compete with Botox for chronic and frequent sufferers.
BoluoC (NASDAQ:LBKXU) has filed for a $60 million SPAC to bring a fresh Asia-based team with blockchain expertise to a target search. The new SPAC is offering investors 1/2 warrant in each unit and a potential shot at a redemption opportunity 18 months after IPO. If the SPAC wishes to extend its lifespan beyond this...
At the SPAC of Dawn With an increasingly thick crowd of crypto treasury deals coming to market via SPACs simultaneously, there was a sign late last week that they may now be coming at a one-in-one-out basis. A proposed combination between Gores X (NASDAQ:GTEN) and Joe McCann-led Solana treasury has reportedly fallen through according to...
An in-depth discussion with Sebastian Bea, President & Head of Investments at ReserveOne, and Vik Mittal, Managing Member at Meteora Capital Partners If there has been one hot summer trend among SPACs, it has been the crypto treasury business combination. To help better understand this new genre of SPAC deal, we sat down with Sebastian...
Terms Tracker for the Week Ending August 8, 2025 Welcome to our weekly column where we discuss the findings from our IPO terms tracker based on the previous week’s pricings. The Terms Tracker post will not have a written summary this week due to vacations, but all data and charts below have been updated. We’ll...
Hall Chadwick (NASDAQ:HCACU) has filed for a $180 million SPAC to bring a team with strong ties to the Outback for a walkabout to find a technology target. The new SPAC is offering investors one right to a 1/10 share in each unit, no overfunding and a 24-month initial timer on its deal search. It...